Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8245245 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 7 Pages |
Abstract
Conclusions: For patients treated by permanent radioisotopic implant for prostate cancer, the definition nadir + 2 ng/mL provides the best surrogate for failure throughout the entire follow-up period, similar to patients treated by external beam radiotherapy. Therefore, the same PSA failure definition could be used for both modalities. For brachytherapy patients with long-term follow-up, at least 6 years, defining failure as exceeding an absolute PSA level in the 0.5 ng/mL range may be reasonable.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Deborah A. M.D., Larry B. M.S., Louis M.D., David C. M.D., John C. M.D., Brian J. M.D., Jay P. M.D., Anthony L. M.D., Michael J. M.D., Thomas M. M.D., Mohamed M.D., Eric M. M.D.,